Subscribe to Newsletter
Subspecialties Retina

The Regeneration Game

| Ruth Steer

Could a successful treatment for dry AMD be on the horizon?

Subspecialties Glaucoma

Change the Channel, Please!

A new OCT-based method lets you see aqueous movement in collector channels…

Business & Profession Other

That’s Life

| Mark Hillen

There will always be people who are left behind by MedTech advances.

Subspecialties Retina

Management of Retinal Disease: Advances in Treatment and Clinical Practice

| Sponsored by Bayer

The 3rd Global Retinal Network Program Annual Meeting

Business & Profession Other

Benchmarking the Power List

| Mark Hillen

The who, what, where and why of this year’s top 100.

Subspecialties Cataract

Great Minds Look Ahead

The 2018 Power List nominees share their thoughts on the future of ophthalmology.

Business & Profession Other

Welcome to the Power List 2018

| Mark Hillen

Who are the influencers in eyecare today?

Subspecialties Retina

An ARIStocratic Endeavor

| Mark Hillen

Looking into why some patients with early-stage AMD progress to late-stage within five years

Subspecialties Retina

The Best Treatment

| Ruth Steer

Is gene therapy the answer to an untreatable form of macular degeneration?

Subspecialties Retina

VEGF Veteran

| Napoleone Ferrara

Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: